3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Neoplasm Metastasis
19
Skin Neoplasms
15
Carcinoma, Renal Cell
13
Leukemia, Myeloid, Acute
12
Kidney Neoplasms
11
Leukemia
9
Neoplasms
7
Uterine Cervical Neoplasms
5
Lymphoma
5
Congenital Abnormalities
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Carcinoma, Non-Small-Cell Lung
4
Vaginal Neoplasms
2
Penile Neoplasms
2
Papillomavirus Infections
2
Oropharyngeal Neoplasms
2
Melanoma, Experimental
2
Lymphoma, Mantle-Cell
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Brain Neoplasms
2
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
aldesleukin
×
Clear all
No trials found.